Table 1 FRET efficiency (E%) and donor-acceptor distances r.

From: Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9 and 2B7 and Impacts on Glucuronidation Activity

  FRET efficiency E % Donor-acceptor distance r (nm) n
CFP/YFP −1.56 ± 4.8 >10 5
CFP-linker-YFP 17.4 ± 4.8 6.92 21
1A1*1CFP/1A9*1YFP 18.7 ± 8.2 6.74 14
1A1*1CFP/1A9*2YFP 12.3 ± 4.1 7.32 15
1A1*1CFP/1A9*3YFP 24.3 ± 8.3 6.38 9
1A1*1CFP/1A9*5YFP 10.3 ± 7.4 7.57 18
1A1*1CFP/2B7*1YFP 20.7 ± 6.9 6.60 15
1A1*1CFP/2B7*71SYFP 9.94 ± 4.9 7.62 13
1A1 *1CFP/2B7*2YFP 6.41 ± 2.4 8.25 10
1A1 *1CFP/2B7*5YFP 9.38 ± 7.7 7.70 23
1A1*1bCFP/1A9*1YFP 9.29 ± 5.5 7.71 25
1A1*1bCFP/1A9*2YFP 5.33 ± 3.7 8.52 19
1A1*1bCFP/1A9*3YFP 6.51 ± 3.6 8.23 23
1A1*1bCFP/1A9*5YFP 8.10 ± 3.9 7.91 10
1A1*1bCFP/2B7*1YFP 8.00 ± 4.7 7.93 17
1A1*1bCFP/2B7 *71SYFP 3.19 ± 4.4 9.32 20
1A1*1bCFP/2B7*2YFP 5.36 ± 3.6 8.51 11
1A1*1bCFP/2B7*5YFP −0.74 ± 2.9 >10 10
1A9*1CFP/2B7 *1YFP 17.9 ± 7.3 6.80 16
1A9*1CFP/2B7*71SYFP 11.8 ± 7.5 7.38 12
1A9*1CFP/2B7*2YFP 6.57 ± 2.6 8.21 12
1A9*1CFP/2B7*5YFP 9.53 ± 5.7 7.68 11
1A9*2CFP/2B7*1YFP 10.3 ± 3.7 7.57 8
1A9*2CFP/2B7*71SYFP 9.23 ± 5.5 7.72 25
1A9*2 CFP/2B7*2YFP 12.3 ± 2.1 7.32 13
1A9*2CFP/2B7*5YFP 3.81 ± 4.1 9.04 15
1A9*3CFP/2B7*1YFP 9.03 ± 5.8 7.75 14
1A9*3CFP/2B7*71SYFP 9.31 ± 5.4 7.71 10
1A9*3CFP/2B7*2YFP 4.76 ± 2.9 8.69 10
1A9*3CFP/2B7*5YFP 12.2 ± 4.3 7.33 16
1A9*5CFP/2B7*1YFP 11.4 ± 6.8 7.42 13
1A9*5CFP/2B7*71SYFP 7.71 ± 4.4 7.98 26
1A9*5CFP/2B7*2YFP 4.88 ± 2.3 8.66 17
1A9*5CFP/2B7*5YFP 13.4 ± 7.2 7.20 17
  1. n is the sample size.